Revici therapy

(redirected from Lipid therapy)

Revici therapy

Pseudomedicine
A cancer therapy based on Revici’s theory of disease dualism, which holds that disease is nothing more than an imbalance between anabolism and catabolism. According to the Revici framework, diseases can be controlled by determining the nature of a biological imbalance and providing the substance that corrects it; it is said to detect catabolic or anabolic processes by measuring urinary pH. Catabolic agents include fatty acids, magnesium, selenium and sulphur; anabolic agents include caffeine, iron, lipols, lithium and zinc.

The method has no demonstrable efficacy and is based on no known or established scientific principle.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
Effects of combination lipid therapy in type 2 diabetes mellitus.
Particularly, low-density lipoprotein cholesterol (LDL-C) is a main target for lipid therapy.[10],[11] Statin therapy is an effective and safe cholesterol-lowering agent [12],[13] that is recommended for all patients with diabetes at risk for vascular events.[14],[15]
(11) among physicians who frequently use local anesthesia, it was found that 65.7% of physicians in all branches had never heard of this treatment in relation to LATS and 21.4% said they could not recall, whereas 70.4% of anesthetists were aware of lipid therapy. Similarly, a survey of residents from all branches conducted by Karasu et al.
(8) The infusion rates of adrenalin and noradrenalin were reduced rapidly due to good response to lipid therapy. The treatments and follow-up are given in Table 1.
Such an intervention costs little, compared with the recent additions to the cardiovascular pharmacopeia in both heart failure and lipid therapy.
Additionally, ACC/AHA resource limitations precluded the review of Apo B and other lipid or lipoprotein measures for guiding lipid therapy. (36)
Lipid therapy complication may cause allergic reactions, liver function impairment, pancreatitis, hypercoagulability state and fluid overload.
The team then analyzed this finding in relation to the MRI results of the glycemic control study, which had shown preserved brain volume associated with intensive management in both the blood pressure and lipid therapy groups.
When those guidelines are delivered, conventional targets and goals for lipid therapy and CVD prevention may change dramatically, or not at all.
Lipid therapy in people with diabetes should ideally have low risk of drug -drug interactions.
Recent research into using lipid therapy to repair mitochondria in cells seems to be helpful for MS patients.